Bull
$60.05
Precio del escenario
$56.350
-0.642 (-1.14%)Al cierre
H.B. Fuller Company is a pureplay adhesives company. It operates as a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. Its Hygiene, Health and Consumable Adhesives segment manufactures and supplies adhesive products in the assembly, packaging, converting, nonwoven and hygiene, health and beauty, graphic arts and envelope markets. Its Engineering Adhesives segment produces and supplies industrial adhesives, such as reactive, light cure, two-part liquids, polyurethane, silicone, film and fast cure products. The Building Adhesive Solutions segment includes products used for the commercial roofing industry (pressure-sensitive adhesives, tapes and sealants) and heating, ventilation and air conditioning and insulation applications (duct sealants, weather barriers and fungicidal coatings and block fillers). It also includes caulks and sealants for the consumer market and professional trade, sold through retailers.
H.B. Fuller Company is currently a hold due to its mixed performance indicators. The stock is trading at $56.35, which is significantly below its 52-week high of $68.63, suggesting potential for recovery. However, the RSI is at 31.291, indicating it is oversold, which could mean a rebound is possible. The forward P/E ratio is 10.627, suggesting it is undervalued compared to its earnings potential. The main risk is the recent decline in stock price, which has fallen 4% over the last 5 days and 6.61% year-to-date, indicating ongoing market volatility.
Deutsche Bank
$72
2026-06-30
Deutsche Bank
2026-06-30
Precio objetivo
$72
Citi
$75
2026-06-30
Citi
2026-06-30
Precio objetivo
$75
Seaport Research
$80
2026-06-26
Seaport Research
2026-06-26
Precio objetivo
$80
JPMorgan
$67
2026-06-26
JPMorgan
2026-06-26
Precio objetivo
$67
UBS
$71
2026-06-17
UBS
2026-06-17
Precio objetivo
$71
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Ancora Reaffirms Proposal to Acquire H.B. Fuller’s BAS Segment

H.B. Fuller Rejects Acquisition Proposal, Highlights Future Growth Potential

Engine Capital Urges H.B. Fuller Board to Seriously Consider Acquisition Proposal

H.B. Fuller Shareholders Approve AMS Acquisition

H.B. Fuller Receives Acquisition Proposal
H.B. Fuller Company is a pureplay adhesives company. It operates as a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. Its Hygiene, Health and Consumable Adhesives segment manufactures and supplies adhesive products in the assembly, packaging, converting, nonwoven and hygiene, health and beauty, graphic arts and envelope markets. Its Engineering Adhesives segment produces and supplies industrial adhesives, such as reactive, light cure, two-part liquids, polyurethane, silicone, film and fast cure products. The Building Adhesive Solutions segment includes products used for the commercial roofing industry (pressure-sensitive adhesives, tapes and sealants) and heating, ventilation and air conditioning and insulation applications (duct sealants, weather barriers and fungicidal coatings and block fillers). It also includes caulks and sealants for the consumer market and professional trade, sold through retailers. It operates in the Basic Materials sector (ADHESIVES & SEALANTS industry).
H.B. Fuller Company is currently a hold due to its mixed performance indicators. The stock is trading at $56.35, which is significantly below its 52-week high of $68.63, suggesting potential for recovery. However, the RSI is at 31.291, indicating it is oversold, which could mean a rebound is possible. The forward P/E ratio is 10.627, suggesting it is undervalued compared to its earnings potential. The main risk is the recent decline in stock price, which has fallen 4% over the last 5 days and 6.61% year-to-date, indicating ongoing market volatility.
8 analysts cover FUL: 1 rate it Buy, 7 Hold and 0 Sell. The average price target is 70.00.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.